康华生物：股东宁波圣道及其一致行动人计划减持不超过2.44%公司股份

Core Viewpoint - Shareholders Ningbo Shengdao and its concerted parties plan to reduce their holdings in Kanghua Biological by up to 2.44% of the company's shares due to personal funding needs [1] Summary by Relevant Sections - Shareholder Actions - Ningbo Shengdao and Zibo Taige plan to reduce their holdings by a maximum of 3,165,765 shares, which represents approximately 2.4362% of the total share capital after excluding shares in the company's repurchase account [1] - Reason for Reduction - The reduction is attributed to the shareholders' personal funding requirements [1] - Source of Shares - The shares to be reduced are sourced from those issued prior to the company's initial public offering and from capital reserves converted into share capital [1]